Fitness-to-Drive Tests May Fail Drivers from Different Cultures and Languages

When a physician decides whether a patient is medically fit to hold a driving license, the decision often rests on a handful of laboratory values and standardized questionnaires. Blood tests for alcohol markers, hair analyses, urine screens, and psychometric instruments have become the backbone of traffic medicine across Europe and beyond. Yet according to a correspondence published in the International Journal of Legal Medicine by Cristian Palmiere of the University Centre of Legal Medicine Lausanne-Geneva, these apparently objective tools carry hidden assumptions about culture, language, and social circumstance that can distort results and produce inequitable outcomes for drivers from minority backgrounds.

The core argument of the correspondence is that fitness-to-drive assessment has become fixated on the biomarker at the expense of context. Biomarkers such as carbohydrate-deficient transferrin in serum, ethyl glucuronide in hair, and phosphatidylethanol in dried blood spots are powerful indicators of alcohol consumption, and their technical performance has been extensively validated. Recent comparative work, cited in the correspondence, has examined whether serum carbohydrate-deficient transferrin or hair ethyl glucuronide offers the more reliable tool for diagnosing alcohol abuse, and protocols now exist for quantifying phosphatidylethanol in dried blood spots to monitor abstinence. Studies in driver’s license regranting cases have combined hair ethyl glucuronide, urinary ethyl glucuronide and ethyl sulfate, and capillary dried blood spot phosphatidylethanol to reconstruct a person’s drinking history. These methods are genuinely impressive pieces of analytical chemistry.

The problem, Palmiere argues, is not the chemistry but the interpretation. Biomarker concentrations do not exist in a social vacuum. Patterns of alcohol consumption vary enormously between cultures, and reference intervals and decision thresholds are typically derived from populations whose drinking habits, body compositions, and genetic backgrounds may differ from those of the person being tested. A threshold calibrated in one population may flag as abnormal a pattern of consumption that is unremarkable in another, or conversely may miss hazardous drinking that presents atypically. Without awareness of these population-level differences, a laboratory value that looks like a clean, objective answer can quietly encode the demographics of the population in which it was validated.

The same concern applies with even greater force to the screening questionnaires that sit alongside laboratory testing. The Alcohol Use Disorders Identification Test, developed under the auspices of the World Health Organization, is one of the most widely used instruments for detecting excessive drinking in primary care and in traffic medicine. Its diagnostic performance in detecting alcohol use disorders in the general population has been studied extensively, and validated translations exist, including a French version whose reliability and validity in primary care settings have been documented. But translation is not equivalence. Idioms about drinking, culturally shaped patterns of what counts as a drink, and differing willingness to disclose personal behavior to an authority figure can all shift how respondents answer. A questionnaire that performs well in its original cultural setting may systematically under- or overestimate alcohol problems in respondents from other backgrounds, and the correspondence suggests that this possibility is too rarely acknowledged in the medico-legal context.

Linguistic barriers compound the psychometric ones. Fitness-to-drive evaluations are high-stakes encounters in which the person being assessed has strong incentives to present themselves favorably, and the assessor must judge not only what is said but how it is said. When the assessed person and the assessor do not share a fluent common language, or when interpretation is improvised rather than professional, subtle cues of evasiveness or misunderstanding may reflect communication difficulty rather than deception or impairment. Screening instruments administered in a language the respondent does not command lose their validated properties entirely, yet the correspondence implies that such administrations still occur and that their results still carry weight in licensing decisions.

Structural factors add a third layer of inequity. Access to driving is not a luxury in many communities; it is a precondition of employment, caregiving, and basic participation in social life, particularly in rural and peri-urban areas poorly served by public transport. A person who loses a license after a positive screening result faces consequences that ripple through an entire household, and the ability to navigate the regranting process, including repeated testing, documentation requirements, and sometimes costly follow-up assessments, is unevenly distributed across social groups. People with precarious employment, limited health literacy, or insecure immigration status may struggle to comply with procedural demands that more advantaged drivers meet without difficulty, so identical medical findings can lead to very different practical outcomes depending on the driver’s circumstances.

The correspondence situates these concerns within a specific legal framework, drawing on the Swiss Federal Act on Road Traffic and the Swiss Ordinance on the Admission of Persons and Vehicles to Road Traffic. Swiss law, like the law of many European jurisdictions, ties license retention and regranting to medical assessments of fitness to drive, including in cases involving alcohol abuse and psychotropic substance use. Scholarly work on medicinal drugs and fitness to drive, and on psychotropic substance abuse and driving license eligibility in Italy, illustrates how widespread these assessment regimes have become. Where the law mandates a medical judgment, the fairness of the underlying instruments becomes a matter of legal as well as clinical significance, because an inequitable test translates directly into an inequitable sanction.

What would a more equitable assessment look like? The correspondence does not propose abandoning biomarkers or questionnaires, which would be neither feasible nor scientifically justified. Instead, it points toward a more contextualized practice: awareness of the population-specific limits of reference intervals and cut-offs, use of professionally translated and locally validated instruments wherever possible, professional interpretation rather than ad hoc language support, and a structural understanding of how compliance burdens fall unevenly. It also implies that assessors should treat convergent evidence, combining laboratory markers, validated questionnaires, clinical examination, and driving history, rather than elevating any single value into a verdict. The literature on combining carbohydrate-deficient transferrin with ethyl glucuronide in hair, for example, already reflects the logic that no single marker is definitive; the equity argument extends that logic from analytical uncertainty to social context.

The wider significance of the argument reaches beyond traffic medicine. Fitness-to-drive assessment is one of many medico-legal domains in which standardized instruments, developed and validated in particular populations, are applied to increasingly diverse societies. Forensic toxicology, psychiatric evaluation, and occupational medicine all face versions of the same problem: tools that are objective within their validation samples can become instruments of disparity when transplanted without scrutiny. The correspondence’s contribution is to name this problem explicitly in a domain where the stakes, both for road safety and for individual liberty and livelihood, are unusually concrete.

Published as a correspondence in the International Journal of Legal Medicine, the piece is deliberately concise, and it raises questions more than it settles them. How large are the cultural and linguistic effects on biomarker interpretation and questionnaire performance in real licensing populations? Which jurisdictions have already adapted their assessment protocols, and which continue to apply one-size-fits-all thresholds? Those empirical questions now await the field’s attention. What the correspondence makes clear is that the pursuit of road safety through medical assessment cannot be separated from the pursuit of fairness in how that assessment is designed, administered, and interpreted. A system that protects the public from genuinely impaired drivers while treating every driver, whatever their language or background, as equally credible and equally comprehensible, is the standard toward which the field is being asked to move.

Subject of Research: Equity and validity in medical fitness-to-drive assessment

Article Title: Beyond the biomarker: cultural, linguistic, and structural equity in fitness-to-drive medical assessment

Article References: Palmiere, C. (2026). Beyond the biomarker: cultural, linguistic, and structural equity in fitness-to-drive medical assessment. International Journal of Legal Medicine. https://doi.org/10.1007/s00414-026-03937-4

Image Credits: AI Generated

DOI: 10.1007/s00414-026-03937-4

Keywords: fitness to drive, legal medicine, biomarkers, alcohol abuse screening, AUDIT, carbohydrate-deficient transferrin, ethyl glucuronide, phosphatidylethanol, health equity, psychometrics, road traffic medicine, Swiss road traffic law